U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CETRELIMAB
LYK98WP91F
Investigational
General
Names
8
Identifiers
7
Subunits
4
Related Substances
1
CETRELIMAB
LYK98WP91F
Investigational
General
Approval Year
Unknown
149,124
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JNJ-63723283 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-63723283 .KAPPA.-CHAIN, DIMER
Preferred Name
English
CETRELIMAB
Official Name
English
cetrelimab [INN]
Common Name
English
CETRELIMAB [USAN]
Common Name
English
Cetrelimab [WHO-DD]
Common Name
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
USAN
FG-99
PRIMARY
NCI_THESAURUS
C129448
PRIMARY
FDA UNII
LYK98WP91F
PRIMARY
CAS
2050478-92-5
PRIMARY
SMS_ID
100000178251
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
LYK98WP91F
CETRELIMAB